Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market. Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are two stocks under $50 that could 10x and one that may have trouble. One Stock Under $50 to Sell: AMN Healthcare Services (AMN) Share Price: $22.94 With a network of thousands of healthcare professionals ranging from nurses to physicians to executives, AMN Healthcare (NYSE:AMN) provides healthcare workforce solutions including temporary staffing, permanent placement, and technology platforms for hospitals and healthcare facilities across the United States. Why Should You Dump AMN? Declining travelers on assignment over the past two years suggest it might have to lower prices to accelerate growth Sales are expected to decline once again over the next 12 months as it continues working through a challenging demand environment Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability At $22.94 per share, AMN Healthcare Services trades at 18.9x forward P/E. Read our free research report to see why you should think twice about including AMN in your portfolio, it’s free. Two Stocks Under $50 to Watch: Cadre (CDRE) Share Price: $34.93 Originally known as Safariland, Cadre (NYSE:CDRE) specializes in manufacturing and distributing safety and survivability equipment for first responders. Why Are We Positive On CDRE? Solid 9.7% annual revenue growth over the last two years indicates its offering’s solve complex business issues Market share is on track to rise over the next 12 months as its 19.3% projected revenue growth implies demand will accelerate from its two-year trend Earnings growth has trumped its peers over the last two years as its EPS has compounded at 19.7% annually Cadre is trading at $34.93 per share, or 21.9x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free. Verra Mobility (VRRM) Share Price: $24.53 Managing over 165 million tolling transactions per year, Verra Mobility (NYSE:VRRM) is a leading provider of smart mobility technology that enhances safety, efficiency, and convenience on roadways. Why Is VRRM a Good Business? Annual revenue growth of 13.8% over the last five years was superb and indicates its market share increased during this cycle Offerings are mission-critical for businesses and lead to a best-in-class gross margin of 62.1% Strong free cash flow margin of 20% enables it to reinvest or return capital consistently, and its recently improved profitability means it has even more resources to invest or distribute Story Continues Verra Mobility’s stock price of $24.53 implies a valuation ratio of 18x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free. High-Quality Stocks for All Market Conditions Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. View Comments
2 Stocks Under $50 to Keep an Eye On and 1 to Turn Down
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...